Skip to main content
Smart Investors Daily
PH

AMEX · PHGE

BiomX Inc.

Healthcare · Biotechnology

$1.62

Up+$0.23 (+14.20%)

Updated Sep 10, 2026, 11:58 PM

SID Score

4.6/10

Composite research score

Smart Money

Institutional and insider signal

Market cap
3.74M
P/E ratio
-0.11
Dividend yield
0.00%
52-week range
$0.12 – $12.29
Volume
745.65K
Avg. volume
70.53K

Price performance

PHGE price history

1M range · 0 trading sessions · Daily adjusted prices

PHGE does not have enough price history for the selected period.

Data unavailable

Market data is busy. Please try again shortly.

Latest PHGE news

The latest Smart Investors Daily articles mentioning PHGE.

PHGE research

Overview

Company profile and research snapshot.

Company profile

BiomX Inc is engaged in developing both natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic fibrosis and diabetic foot osteomyelitis. It discovers and validates proprietary bacterial targets and customizes phage compositions against these targets, and applies its BOLT (BacteriOphage Lead to Treatment) platform to customize phage compositions against these targets. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF. Its BX211 - Treatment of Diabetic Foot Osteomyelitis (DFO).

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$2.00
Implied upside
Analysts
8
PHGE recent ratings
DateFirmRatingTarget
Mar 9, 2026HC Wainwright & Co.Neutral
Nov 26, 2025HC Wainwright & Co.Buy
Nov 25, 2025HC Wainwright & Co.Buy
Aug 20, 2025HC Wainwright & Co.Buy
May 16, 2025HC Wainwright & Co.Buy
Open full forecast

News briefing

No generated briefing is available yet.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.